Developer docs
API playgroundTry for free, no card

Search company profiles

Maihub

Full company profile

uuid0003e6w

Namestring
Maihub
Legal namestring
MAIHUB CORPORATION (주)마이허브
Websiteurl
maihub.ai
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Maihub is a Seoul-based medical AI platform company founded in 2022 that builds maiLink, a hybrid on-premise and cloud platform enabling hospitals to deploy and orchestrate multiple AI diagnostic tools from a single integration point with PACS and EMR systems. The platform currently aggregates 40+ AI modules contributed by 20 Korean developers across imaging modalities (X-ray, mammography, CT, MRI, ultrasound, fundus) and structured signals (ECG, health checkup data), spanning computer vision, predictive risk scoring, anomaly detection, and triage/notification workflows. Underlying capability is backed by 30 patents and a stack of regulatory clearances including Korean MFDS for maiLink and InsightVue, ISO 13485:2016, GMP, Malaysia MDA, Indonesia BPOM, and U.S. FDA 510(k) obtained in January 2026.

Maihub's commercial model is a B2B enterprise SaaS engine with monthly or annual subscriptions and usage-based pricing on hospitals, monetizing access to the integrated AI suite and the underlying viewer/workflow. In March 2026 the company launched maiReport, a patient-facing healthcare app that delivers AI-generated diagnostic reports to consumers via QR code shared from partner hospitals, adding a B2H2C consumer revenue stream layered on top of the enterprise platform. Distribution is direct enterprise sales to hospitals and clinics in Korea and other served markets, supplemented by hospital-driven consumer distribution for maiReport.

The company serves over 1,500 hospitals and clinics worldwide, operates a wholly-owned Indonesian subsidiary established in 2026, and has secured roughly $6.5M across disclosed funding rounds (Pre-Series A 2023 led by Mashup Ventures, Series A+ 2025 with Evergreen Investment Partners, FuturePlay, and Intops Investment) alongside an Indonesian FDA (BPOM) certification and a U.S. FDA clearance that together underpin a stated Southeast Asia and United States expansion plan. In 2025 Maihub acquired the Vuno Boneage AI Solution, extending the maiLink module catalog with bone-age assessment capability.

Short descriptiontext

Maihub, founded in 2022 in Seoul, operates maiLink, a hybrid on-premise and cloud medical AI integration platform that lets hospitals run multiple diagnostic AI modules (imaging, ECG, health checkup) from a single PACS/EMR-connected workflow, and complements it with maiReport, a patient-facing app for AI-generated health reports. It serves over 1,500 hospitals and clinics globally and is expanding into Southeast Asia and the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical AI platform, diagnostic imaging AI, healthcare workflow software, clinical decision support, AI integration platform
Industry4 codes
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAEANAI
AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Medical AI Software (Clinical Diagnostic Imaging Platform)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1maiLink Platform Subscriptions
TypeSubscription Recurring
Description

AI solutions available through monthly or annual subscription plans, allowing hospitals to select and deploy multiple AI diagnostic tools on a recurring basis.

maihub.ai
2Usage-Based Pricing
TypeUsage Based
Description

Usage-based pricing for AI solutions providing maximum cost efficiency for hospitals with varying diagnostic volumes.

maihub.ai
3maiReport Consumer App
TypeSubscription Recurring
Description

Patient-facing app connecting AI diagnostics directly to consumers through hospital partnerships, enabling B2H2C revenue model.

koreabiomed.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Flexible Subscription Plans
ModelSubscriptionBilling cadenceMonthly
Notes

AI Solutions available through monthly or annual subscription plans with usage-based pricing for maximum cost efficiency. Hospitals can select only the AI solutions relevant to their clinical needs and institution size.

maihub.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 2 records shown
1maiLink
Description

Medical AI integration platform that enables hospitals to deploy multiple AI diagnostic tools with hybrid on-premise and cloud-based deployment.

maihub.ai
+1 more record
Core offering1 text field

Maihub provides the maiLink medical AI integration platform, a hybrid on-premise and cloud solution that enables hospitals and clinics to deploy and run multiple AI diagnostic tools from a single unified interface, with seamless PACS and EMR integration across imaging modalities including X-ray, mammography, CT, MRI, ultrasound, and ECG. The platform aggregates more than 40 AI solutions from 20 Korean AI companies, and is complemented by the maiReport patient-facing app that delivers AI-generated health reports to consumers via QR code, enabling a B2H2C distribution model.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Maihub operates a unified medical AI platform that integrates multiple AI solutions into clinical workflows, consisting of two core products: maiLink (a medical AI integration platform for hospitals enabling deployment of multiple AI diagnostic tools from a single platform) and maiReport (a patient-facing healthcare app that delivers AI-powered health reports directly to consumers via B2H2C model). The platform offers 20+ AI solutions from various Korean companies including chest X-ray, mammography, ultrasound, fundus, CT, and ECG-based diagnostic tools covering cardiovascular, neurological, orthopedic, and general disease detection.

Product and service3 records
1maiLink Medical AI Integration Platform
CategoryMedical AI Platform (Enterprise Software)
Description

Unified hybrid on-premise and cloud platform that enables hospitals and clinics to deploy multiple AI diagnostic solutions from a single interface, with seamless PACS and EMR integration across X-ray, mammography, CT, MRI, ultrasound, fundus, and ECG modalities, and AI results integrated directly into clinical workflows. Sold to hospitals on monthly or annual subscription plans with usage-based pricing.

2maiReport Patient Health App
CategoryConsumer Health App
Description

Patient-facing mobile health app that receives AI-generated health reports from hospitals via QR code, enabling consumers to manage health records, simplified checkup results, prescriptions, and family health data in one place. Distributed via hospital partnerships under a B2H2C model.

3InsightVue Medical Device
CategoryRegulated Medical Device
Description

Regulated medical device that received MFDS certification in 2023, representing one of Maihub's certified medical AI solutions within the company's portfolio.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
120 Korean AI Companies
Strategic tierCoreTypeTechnology or Integration
Description

Over 40 AI solutions from 20 Korean companies integrated into the maiLink platform, enabling comprehensive diagnostic capabilities across multiple modalities.

koreabiomed.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Korean-founded medical AI company providing imaging AI solutions (chest X-ray, mammography, pathology) and increasingly an AI platform. Directly comparable as a Korean-headquartered peer pursuing global medical AI market with overlapping imaging AI capabilities that could be integrated via or compete with maiLink.

TypeDirect peer
Description

Korean medical AI company developing AI solutions across radiology, pathology, and biosignals. Highly relevant peer given that Maihub already acquired its Boneage AI Solution, and both compete in the same Korean-origin medical AI ecosystem with overlapping hospital channels.

TypeRegional player
Description

Korean PACS/RIS/medical imaging IT vendor serving global hospitals. Comparable as a regional incumbent in radiology IT infrastructure that Maihub must integrate with (or compete against) for the AI workflow layer, and shares the same Korean origin and hospital customer base.

TypeDirect peer
Description

Israel-based medical AI platform offering AI orchestration across multiple imaging AI models with deep PACS/EHR integration. Direct competitor for maiLink's value proposition in the US and EU, particularly as an enterprise-grade AI orchestration layer for hospital systems.

TypeDirect peer
Description

Australia-based comprehensive imaging AI platform covering chest X-ray, CT, and other modalities with PACS integration. Comparable as a multi-modality AI platform that competes with the breadth of maiLink's integrated AI suite, particularly in APAC and emerging markets.

TypeDirect peer
Description

US-based platform offering AI solutions for stroke, aneurysm, and other cerebrovascular and vascular conditions with workflow integration. Overlaps directly with Maihub's NCCT intracranial hemorrhage, ischemic stroke, and aneurysm AI modules.

TypeDirect peer
Description

UK-based medical imaging AI platform and marketplace that aggregates multiple third-party AI algorithms for hospital deployment. Closest architectural analogue to maiLink's multi-vendor AI integration model, with comparable go-to-market to radiology departments.

TypeBroad incumbent
Description

US-based AI-powered radiology platform acquired by RadNet, offering integrated AI across the imaging workflow. Comparable as a broader incumbent player embedding AI orchestration into radiology operations at scale across US health systems.

TypeBroad incumbent
Description

Microsoft-owned AI-powered clinical workflow and imaging AI marketplace integrated with PowerScribe and EHR systems. A significant incumbent competitor offering AI orchestration embedded into widely deployed radiology reporting platforms.

10Zebra Medical Vision (Nanox)
TypeBroad incumbent
Description

Medical imaging AI company acquired by Nanox, offering broad multi-modality AI solutions and platform distribution. Comparable as a broader imaging AI incumbent that competes on algorithm breadth and global distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maihub

Medical AI Software (Clinical Diagnostic Imaging Platform)maihub.ai

Maihub, founded in 2022 in Seoul, operates maiLink, a hybrid on-premise and cloud medical AI integration platform that lets hospitals run multiple diagnostic AI modules (imaging, ECG, health checkup) from a single PACS/EMR-connected workflow, and complements it with maiReport, a patient-facing app for AI-generated health reports. It serves over 1,500 hospitals and clinics globally and is expanding into Southeast Asia and the United States.

What Maihub does

Maihub is a Seoul-based medical AI platform company founded in 2022 that builds maiLink, a hybrid on-premise and cloud platform enabling hospitals to deploy and orchestrate multiple AI diagnostic tools from a single integration point with PACS and EMR systems. The platform currently aggregates 40+ AI modules contributed by 20 Korean developers across imaging modalities (X-ray, mammography, CT, MRI, ultrasound, fundus) and structured signals (ECG, health checkup data), spanning computer vision, predictive risk scoring, anomaly detection, and triage/notification workflows. Underlying capability is backed by 30 patents and a stack of regulatory clearances including Korean MFDS for maiLink and InsightVue, ISO 13485:2016, GMP, Malaysia MDA, Indonesia BPOM, and U.S. FDA 510(k) obtained in January 2026.

Maihub's commercial model is a B2B enterprise SaaS engine with monthly or annual subscriptions and usage-based pricing on hospitals, monetizing access to the integrated AI suite and the underlying viewer/workflow. In March 2026 the company launched maiReport, a patient-facing healthcare app that delivers AI-generated diagnostic reports to consumers via QR code shared from partner hospitals, adding a B2H2C consumer revenue stream layered on top of the enterprise platform. Distribution is direct enterprise sales to hospitals and clinics in Korea and other served markets, supplemented by hospital-driven consumer distribution for maiReport.

The company serves over 1,500 hospitals and clinics worldwide, operates a wholly-owned Indonesian subsidiary established in 2026, and has secured roughly $6.5M across disclosed funding rounds (Pre-Series A 2023 led by Mashup Ventures, Series A+ 2025 with Evergreen Investment Partners, FuturePlay, and Intops Investment) alongside an Indonesian FDA (BPOM) certification and a U.S. FDA clearance that together underpin a stated Southeast Asia and United States expansion plan. In 2025 Maihub acquired the Vuno Boneage AI Solution, extending the maiLink module catalog with bone-age assessment capability.

Maihub firmographics

Firmographics
Name
Maihub
Legal name
MAIHUB CORPORATION (주)마이허브
Website
https://maihub.ai
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Maihub, founded in 2022 in Seoul, operates maiLink, a hybrid on-premise and cloud medical AI integration platform that lets hospitals run multiple diagnostic AI modules (imaging, ECG, health checkup) from a single PACS/EMR-connected workflow, and complements it with maiReport, a patient-facing app for AI-generated health reports. It serves over 1,500 hospitals and clinics globally and is expanding into Southeast Asia and the United States.
Ownership category
akta.pro rank

Maihub industry classification

Industry
Product category
Medical AI Software (Clinical Diagnostic Imaging Platform)
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAEANAI
AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHLACAAAN
EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps
Healthcare & Life Sciences/Digital Health & Health IT/Electronic Health Records (EHR/EMR) & Clinical Documentation

Keywords

  • Medical AI platform
  • Diagnostic imaging AI
  • Healthcare workflow software
  • Clinical decision support
  • AI integration platform

Where Maihub is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

Maihub business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. maiLink Platform Subscriptions: AI solutions available through monthly or annual subscription plans, allowing hospitals to select and deploy multiple AI diagnostic tools on a recurring basis.
  2. Usage-Based Pricing: Usage-based pricing for AI solutions providing maximum cost efficiency for hospitals with varying diagnostic volumes.
  3. maiReport Consumer App: Patient-facing app connecting AI diagnostics directly to consumers through hospital partnerships, enabling B2H2C revenue model.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFlexible Subscription Plans

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Maihub product offering

Product offering

Core offering

Maihub provides the maiLink medical AI integration platform, a hybrid on-premise and cloud solution that enables hospitals and clinics to deploy and run multiple AI diagnostic tools from a single unified interface, with seamless PACS and EMR integration across imaging modalities including X-ray, mammography, CT, MRI, ultrasound, and ECG. The platform aggregates more than 40 AI solutions from 20 Korean AI companies, and is complemented by the maiReport patient-facing app that delivers AI-generated health reports to consumers via QR code, enabling a B2H2C distribution model.

Product overview

Maihub operates a unified medical AI platform that integrates multiple AI solutions into clinical workflows, consisting of two core products: maiLink (a medical AI integration platform for hospitals enabling deployment of multiple AI diagnostic tools from a single platform) and maiReport (a patient-facing healthcare app that delivers AI-powered health reports directly to consumers via B2H2C model). The platform offers 20+ AI solutions from various Korean companies including chest X-ray, mammography, ultrasound, fundus, CT, and ECG-based diagnostic tools covering cardiovascular, neurological, orthopedic, and general disease detection.

Differentiator

Problem solved

Functional benefit

Brands

  • maiLink: Medical AI integration platform that enables hospitals to deploy multiple AI diagnostic tools with hybrid on-premise and cloud-based deployment.
  • maiReport

Products and services

  • maiLink Medical AI Integration Platform Unified hybrid on-premise and cloud platform that enables hospitals and clinics to deploy multiple AI diagnostic solutions from a single interface, with seamless PACS and EMR integration across X-ray, mammography, CT, MRI, ultrasound, fundus, and ECG modalities, and AI results integrated directly into clinical workflows. Sold to hospitals on monthly or annual subscription plans with usage-based pricing.
  • maiReport Patient Health App Patient-facing mobile health app that receives AI-generated health reports from hospitals via QR code, enabling consumers to manage health records, simplified checkup results, prescriptions, and family health data in one place. Distributed via hospital partnerships under a B2H2C model.
  • InsightVue Medical Device Regulated medical device that received MFDS certification in 2023, representing one of Maihub's certified medical AI solutions within the company's portfolio.

Companies that use Maihub

Customer profile

Segments2 records

Ideal customer profiles2 records

Maihub technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Maihub partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 20 Korean AI CompaniescoreTechnology or IntegrationOver 40 AI solutions from 20 Korean companies integrated into the maiLink platform, enabling comprehensive diagnostic capabilities across multiple modalities.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Maihub competitors and assessment

Company assessment

Direct peers

  • Lunit: Korean-founded medical AI company providing imaging AI solutions (chest X-ray, mammography, pathology) and increasingly an AI platform. Directly comparable as a Korean-headquartered peer pursuing global medical AI market with overlapping imaging AI capabilities that could be integrated via or compete with maiLink.
  • Vuno: Korean medical AI company developing AI solutions across radiology, pathology, and biosignals. Highly relevant peer given that Maihub already acquired its Boneage AI Solution, and both compete in the same Korean-origin medical AI ecosystem with overlapping hospital channels.
  • Aidoc: Israel-based medical AI platform offering AI orchestration across multiple imaging AI models with deep PACS/EHR integration. Direct competitor for maiLink's value proposition in the US and EU, particularly as an enterprise-grade AI orchestration layer for hospital systems.
  • Annalise.ai: Australia-based comprehensive imaging AI platform covering chest X-ray, CT, and other modalities with PACS integration. Comparable as a multi-modality AI platform that competes with the breadth of maiLink's integrated AI suite, particularly in APAC and emerging markets.
  • RapidAI: US-based platform offering AI solutions for stroke, aneurysm, and other cerebrovascular and vascular conditions with workflow integration. Overlaps directly with Maihub's NCCT intracranial hemorrhage, ischemic stroke, and aneurysm AI modules.
  • Blackford Analysis: UK-based medical imaging AI platform and marketplace that aggregates multiple third-party AI algorithms for hospital deployment. Closest architectural analogue to maiLink's multi-vendor AI integration model, with comparable go-to-market to radiology departments.

Regional players

  • Infinitt Healthcare: Korean PACS/RIS/medical imaging IT vendor serving global hospitals. Comparable as a regional incumbent in radiology IT infrastructure that Maihub must integrate with (or compete against) for the AI workflow layer, and shares the same Korean origin and hospital customer base.

Broad incumbents

  • DeepHealth (a RadNet company): US-based AI-powered radiology platform acquired by RadNet, offering integrated AI across the imaging workflow. Comparable as a broader incumbent player embedding AI orchestration into radiology operations at scale across US health systems.
  • Nuance Precision Imaging Network (Microsoft): Microsoft-owned AI-powered clinical workflow and imaging AI marketplace integrated with PowerScribe and EHR systems. A significant incumbent competitor offering AI orchestration embedded into widely deployed radiology reporting platforms.
  • Zebra Medical Vision (Nanox): Medical imaging AI company acquired by Nanox, offering broad multi-modality AI solutions and platform distribution. Comparable as a broader imaging AI incumbent that competes on algorithm breadth and global distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Maihub social profiles

Digital presence

Maihub compliance and trust

Trust signal

Compliance7 records

Maihub financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maihub leadership team

Management profile

Number of profiles

Profiles1 record

Maihub subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Maihub funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maihub M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maihub

What does Maihub do?

Maihub provides the maiLink medical AI integration platform, a hybrid on-premise and cloud solution that enables hospitals and clinics to deploy and run multiple AI diagnostic tools from a single unified interface, with seamless PACS and EMR integration across imaging modalities including X-ray, mammography, CT, MRI, ultrasound, and ECG. The platform aggregates more than 40 AI solutions from 20 Korean AI companies, and is complemented by the maiReport patient-facing app that delivers AI-generated health reports to consumers via QR code, enabling a B2H2C distribution model.

Is Maihub a public or private company?

Maihub is a private company. It is classified as venture growth investor backed and is currently operating.

When was Maihub founded?

Maihub was founded in 2022. It employs 11 to 50 people.

Where is Maihub based?

Maihub is headquartered in Seoul, South Korea, in the Asia region.

How does Maihub make money?

Three revenue lines are on record. maiLink Platform Subscriptions are the primary driver. The others are usage-Based Pricing and maiReport Consumer App.

Who are Maihub's main competitors?

Direct peers on record are Lunit, Vuno, Aidoc, Annalise.ai, RapidAI and Blackford Analysis. Infinitt Healthcare is listed as a regional player. Broad incumbents are DeepHealth (a RadNet company), Nuance Precision Imaging Network (Microsoft) and Zebra Medical Vision (Nanox).

Does Maihub have an API?

No public API is recorded for Maihub.

What industry is Maihub in?

Maihub's product category is Medical AI Software (Clinical Diagnostic Imaging Platform). Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAEANAI, AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
KBRMaihub seeks to lower barriers to medical AI adoption with integrated platform strategyMaihub Corp., Korea's only commercialized medical AI integration platform company, announced it has secured over 1,500 paying medical institutions using its maiLink platform and unveiled a global expansion strategy targeting Southeast Asia and the United States. The company launched its patient-centered healthcare app maiReport in March, marking a shift toward a B2H2C business model that connects AI diagnostics directly to consumers. Maihub completed establishment of its Indonesian subsidiary this month and obtained U.S. FDA 510(k) clearance in January, with over 40 AI solutions from 20 Korean companies integrated into its platform.BusinessLineKorea’s AI-Driven Healthcare Technologies Take Centre Stage at the upcoming WHX Bangkok 2026WHX Bangkok 2026, a trade show organized by Informa Markets, will serve as the platform for two Korean companies — Korea Body Information Co., Ltd. and maihub — to debut AI-driven healthcare solutions in the Thai market on July 8–10, 2026. Korea Body Information will unveil Real PT, an AI-powered musculoskeletal diagnostic and exercise prescription platform with 99.3% diagnostic accuracy and over 2.8 million users across 500+ facilities in Korea, while maihub will present its medical AI orchestration platform maiLink (already deployed in 1,300+ institutions globally, with FDA 510(k) and Southeast Asian regulatory approvals) and patient-facing tool maiReport. The event marks both companies' official entry into Thailand and the broader Southeast Asian market, with live demonstrations planned at the Queen Sirikit National Convention Centre in Bangkok.The HinduKorea’s AI-Driven Healthcare Technologies Take Centre Stage at the upcoming WHX Bangkok 2026Two Korean companies, Korea Body Information Co., Ltd. and maihub, will debut their AI-powered healthcare solutions at WHX Bangkok 2026, a medical trade show taking place 8–10 July 2026 in Bangkok. Korea Body Information will showcase Real PT, an AI musculoskeletal diagnostic system with 99.3% accuracy that has been deployed across 500+ facilities in Korea with 2.8 million users, marking the company's first entry into the Thai medical device market. maihub will present its maiLink medical AI platform, already deployed in over 1,300 medical institutions globally with FDA 510(k) and other regulatory approvals, as both companies target Southeast Asia's growing demand for AI-driven healthcare solutions.KBRMaihub secures US FDA clearance for medical AI integration platformMaihub announced that its medical AI integration platform maiLink has received 510(k) clearance from the U.S. FDA for Class II medical devices covering medical image management and processing. This is maiLink's third international regulatory approval, following certifications from Malaysia's Medical Devices Authority and registration with Indonesia's BPOM, with the company planning to use this clearance as a foothold to expand into the U.S. and Latin American markets. The platform, which has been adopted by more than 1,000 medical institutions worldwide with strong uptake in Southeast Asia, connects multiple AI-based diagnostic support solutions using a hybrid on-premises and cloud model.LinkedInAI in Medical Imaging - September Round-upBayer announced its exit from the radiology AI platform market, discontinuing its Calantic Digital Solutions platform and winding down services from subsidiary Blackford Analysis, which had hosted over 150 third-party applications from 60 vendors. The month saw significant market consolidation with three acquisitions (GE HealthCare acquiring icometrix, Lunit Cancer Screening acquiring Prognosia, and VUNO Inc. selling its BoneAge business to maihub Corp.), alongside multiple funding rounds including Cerebriu's €9.4m round and Artrya's A$80m equity offering. An analysis of Medicare claims between 2018-2023 found that over half of the 93,392 submitted claims for AI were denied, with $16m in claims rejected versus $8m approved, highlighting the gap between regulatory clearance and reimbursement for radiology AI vendors.